Davidson Kempner Partners’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Davidson Kempner Partners’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.58K	Buy	+83,332	New	+$8.03K	﹤0.01%	364

Other funds holding PEARW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Davidson Kempner Partners's PEARW Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Pear Therapeutics, Inc. Warrant (PEARW) in Q1 2023: 83,332 shares worth $1.58K. The stake represents ﹤0.01% of the portfolio and ranks #364 among its holdings.

33 funds tracked by Wall St. Rank hold PEARW as of Q1 2023.

Davidson Kempner Partners held 83,332 shares of Pear Therapeutics, Inc. Warrant worth $1.58K as of Q1 2023.
Pear Therapeutics, Inc. Warrant was a new Davidson Kempner Partners position in Q1 2023.
Pear Therapeutics, Inc. Warrant made up ﹤0.01% of Davidson Kempner Partners's portfolio in Q1 2023, its #364 holding.
33 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.